Back
Osisko Gold Royalties Vs. Gilead Sciences Industry Stock Comparison
Buy
67
OR
Osisko Gold Royalties
Last Price:
18.43
Seasonality Move:
2.63%
Buy
54
GILD
Gilead Sciences
Last Price:
83.61
Seasonality Move:
3.02%
Buy
67
Osisko Gold Royalties (OR)
is a Buy
Is Osisko Gold Royalties a Buy, Sell or Hold?
- The current Osisko Gold Royalties [OR] share price is $18.45. The Score for OR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- OR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $83.61. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OR Stock Price Chart
What is Osisko Gold Royalties's stock price today?
-
The Osisko Gold Royalties share price today is $18.45
The current trend is moderately bullish and OR is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $83.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight selling pressure.
OR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 59.13 | Buy |
| Chaikin Money Flow: | -447768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17 - 18.38) | Buy |
| Bollinger Bands (100): | (16.1 - 17.74) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 66.51 | Buy |
| Chaikin Money Flow: | -585562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.57 - 83.53) | Buy |
| Bollinger Bands (100): | (66.1 - 78.82) | Buy |
OR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.42 | Buy |
| 20-day SMA: | 17.7 | Buy |
| 50-day SMA: | 17.42 | Buy |
| 200-day SMA: | 15.99 | Buy |
| 8-day EMA: | 18.42 | Buy |
| 20-day EMA: | 17.97 | Buy |
| 50-day EMA: | 17.47 | Buy |
| 200-day EMA: | 16.17 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.55 | Buy |
| 20-day SMA: | 81.87 | Buy |
| 50-day SMA: | 77.92 | Buy |
| 200-day SMA: | 73.7 | Buy |
| 8-day EMA: | 83.18 | Buy |
| 20-day EMA: | 81.75 | Buy |
| 50-day EMA: | 78.26 | Buy |
| 200-day EMA: | 74.42 | Buy |
Osisko Gold Royalties Earnings Growth & OR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.05 per share, and an increase next year of $0.11 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.21 per share, a decrease this year of $2.96 per share, and an increase next year of $3.34 per share.
Osisko Gold Royalties Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||